News item
UTI pharmacy pilot recommended for expansion despite GP concern
An evaluation says the Tasmanian trial improved access to care, but the RACGP argues patient outcomes were not adequately measured.
This is for Doceo members
Membership is free. Join in a minute, or log in if you’re already a member.